Primary Cutaneous B-cell Lymphoma


July 2021 - Dr. John Zic shares highlights from the USCLC's annual workshop on the biology and treatment of cutaneous B-Cell lymphoma. The USCLC is "a multidisciplinary society of physicians which, through collaborative efforts in research and education, improves the quality of life and prognosis of patients with cutaneous lymphoma."

John Zic, MD, Vanderbilt Dermatology

Webinar: Cutaneous B-cell Lymphomas

August 2020 - Primary cutaneous B-cell lymphomas (CBCL) comprise only 20 - 25 % of all primary cutaneous lymphomas, making it a rarer form of cutaneous lymphoma. Dr. Christiane Querfeld presented an overview of the different types of CBCL, its treatment and responded to pre-submitted questions.

Christiane Querfeld, MD, PhD, Beckman Research Institute, City of Hope National Medical Center

Cutaneous lymphoma 101

Knowing where to start when you learn you have cutaneous lymphoma can be a challenge. Cutaneous lymphoma specialist Dr. Stuart Lessin provides an overview of the important information and concepts every patient with cutaneous lymphoma and caregivers should know.

Treatment Options for Cutaneous B-cell Lymphoma

The types of therapies for cutaneous B-cell lymphoma can vary from a “watch and wait” approach to surgical removal of the lesion, intralesional therapy (injections into the lesion), radiation, biologic agents, or chemotherapy. Learn more about how CBCL may be treated.

Cutaneous B-Cell Lymphoma: What are the variants and how are they treated?

Primary Cutaneous B-cell Lymphoma

Primary cutaneous B-cell lymphomas (CBCLs) are a cutaneous lymphoma (a cancer of white blood cells) that affects B-cells in the skin. Learn more about the diagnosis, variants, treatment options and prognosis of CBCLs.